ARS Pharmaceuticals, Inc. (SPRY)
13.06
+2.11
(+19.27%)
USD |
NASDAQ |
Jan 09, 16:00
13.03
-0.03
(-0.23%)
After-Hours: 20:00
ARS Pharmaceuticals Shareholders Equity (Quarterly): 147.66M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Lipocine, Inc. | 14.14M |
| Inspire Medical Systems, Inc. | 666.46M |
| Vivos Therapeutics, Inc. | 2.532M |
| MBX Biosciences, Inc. | 387.54M |
| CapsoVision, Inc. | 20.44M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 372.80M |
| Total Liabilities (Quarterly) | 225.15M |
| Debt to Equity Ratio | 0.6621 |
| Current Ratio | 6.660 |
| Net Debt Paydown Yield | -1.96% |